ararat
New member
- Joined
- Mar 13, 2010
- Messages
- 1
- Reason
- Learn about ALS
- Country
- US
- State
- WA
- City
- Bremerton
Some 20 years ago, 3 billion dollars was raised by the global community for the goal of mapping out the entire human genome with the ambition of uncovering the underlying mechanisms that were causing cancer. Well, in 2003, the project was successful, the entire human genome was sequenced. Since then, they've sequenced several genomes, the methodology and cost-effectiveness consistently improving, so rapidly, that it's been speculated by some in the research industry that genome-sequencing could essentially cost about the price of an MRI scan in the near future. So far, they've only used healthy specimens. But this made me think, that there must be a wealth of cross-over potential with these developments over to the ALS research field. Does anyone know if any researchers in the field have discussed these possibilities? Is there any posturing towards these avenues as the technology becomes more accessible? Any opinions or discussion points on this subject are very welcome. Thanks
